Risk factors for alloimmunization in patients with sickle cell anemia

Revista da Associacao Medica Brasileira

Volumn 57, Issue 6, 2011, Pages 654-659

  Pinto, Patrícia Costa Alves ^a   Braga, Josefina Aparecida Pellegrini ^b   dos Santos, Amélia Miyashiro Nunes ^b  

^a FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anemia; Blood group antigens; Donor selection; Erythrocyte transfusion; Sickle cell

Indexed keywords

EID: 84855992254     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0104-4230(11)70132-4     Document Type: Article

References (25)

1. Rosse WF, Gallagher D, Kinney TR, Castro O, Moohr J, Wang W. Transfusion and alloimmunization in sickle cell disease. Blood. 1990;76:1431-7.
2. Wayne AS, Schoenike SE, Pegelow CH. Financial analysis of chronic transfusion for stroke prevention in sickle cell disease. Blood. 2000;96:2369-72.
3. Moreira Jr G, Bordin JO, Kuroda A, Kerbauy J. Red blood cell alloimmunization in sichle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil. Am J Hematol. 1996;52:197-200.
4. Castellino SM, Combs MR, Zimmerman SA, Issitt PD, Ware RE. Erythocyte autoantibodies in paediatric patients wich sickle cell disease receiving transfusion therapy: frequency, characteristic and significance. Br J Haematol. 1999;104:189-94.
5. Fabron Junior A. Estudo da significância clínica de aloanticorpos eritrocitários em pacientes com anemia falciforme. Rev Bras Hematol Hemoter. 2001;23:121-2.
6. Amrolia PJ, Almeid A, Halsey C, Roberts IA, Davies SC. Review: therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options. Br J Haematol. 2003;120:725-36.
7. Afenyi-Annan A, Bandarenko N. Transfusion practices for patients with sickle cell disease at a major academic medical center. Immunohematology. 2006;22:103-107.
8. Natukunda B, Schonewille H, Ndugwa C, Brand A. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion. 2010;50:20-5.
9. Olujohungbe A, Hambleton I, Stephens L, Serjeant B, Serjeant G. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol. 2001;113:661-5.
10. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002;42:37-43.
11. Talano JM, Hillery CA, Gottschall JL, Baylerian DM, Scott JP. Delayed hemolytic transfusion reaction/ Hyperhemolysis syndrome in children with sickle cell disease. Pediatrics. 2003;111:661-5.
12. Osby M, Shulman IA. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients. Arch Pathol Lab Med. 2005;129:190-3.
13. Novaretti MCZ, Dorlhiac-Llacer PE, Chamone DAF. Estudo de grupos sangüíneos em doadores de sangue caucasóides e negróides na cidade de São Paulo. Rev Bras Hematol Hemoter. 2000;22:23-32.
14. Castro O. Management of sickle cell disease: recent advances and controversies. Br J Haematol. 1999;107:2-11.
15. New HV. Paediatric transfusion. Vox Sang. 2006;90:1-9.
16. Godfrey GJ, Lockwood W, Kong M, Bertolone S, Ray A. Antibody development inpediatric cell patients undergoing erythocytapheresis. Pediatr Blood Cancer. 2010;55:1134-7.
17. Sakhalkar VS, Roberts K, Hawthorne LM, McCaskill DM, Veillon DM, Caldito GC, et al. Allosensitizacion in patients receiving multiple blood transfusions. Ann N Y Acad Sci. 2005;1054:495-9.
18. Matsuura MM. Imunização eritrocitária em pacientes com doença falciforme no estado do Amazonas. [dissertation]. São Paulo: Escola Paulista de Medicina, Universidade Federal de São Paulo; 2004.
19. Murao M, Viana MB. Risk factors for alloimmunization by patients with sickle cell disease. Braz J Med Biol Res. 2005;38:675-82.
20. Bashawri LA. Red cell alloimunization in sickle-cell anaemia patients. East Mediterr Health J. 2007;13:1181-9.
21. Santos FWR, Magalhães SMM, Mota RMS, Pitombeira MH. Post-transfusion red cell alloimunization in patients with acute disorders and medical emergencies. Rev Bras Hematol Hemoter. 2007;29:369-72.
22. Naoum PC. Interferentes eritrocitários e ambientais na Anemia Falciforme. Rev Bras Hematol Hemoter. 2000;22:5-22.
23. Schonewille H, Watering LMG, Loomans DSE, Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion. 2006;46:250-6.
24. Flickinger C. In search of red blood cells for alloimmunized patients with sickle cell disease. Immunohematology. 2006;22:136-42.
25. Araújo MTF, Medeiros SDVM, Souza MDSA, Bezerra LRM. Freqüência da fenotipagem eritrocitária em pacientes politranfundidos. Rev Bras Hematol Hemoter. 2006;28:334.